	Le Bénéfice D'Exploitation		Date
Agios Pharmaceuticals	USD -121.58M	4.71M	2025-12
Alnylam Pharmaceuticals	USD 29.4M	59.36M	2025-12
Arrowhead Research	USD 40.81M	3.3M	2025-12
Astellas Pharma	JPY 134.54B	30.13B	2025-12
BioCryst Pharmaceuticals	USD -2.54M	10.23M	2024-12
BioMarin Pharmaceutical	USD -31.69M	308.58M	2025-09
Celltrion	KRW 301.04B	58.57B	2025-09
Cspc Pharmaceutical	CNY 1.22B	60.54M	2025-09
Deva Holding AS	TRY 964.87M	240.32M	2023-09
Divis Laboratories Ltd	INR 7.72B	30M	2025-12
Esperion Therapeutics	USD -16.03M	18.6M	2024-09
Exelixis	USD 235.91M	20.45M	2025-12
Halozyme Therapeutics	USD 217.92M	15.48M	2025-09
Ionis Pharmaceuticals	USD -160.18M	300.02M	2025-09
Kangmei Pharma	CNY -26.7M	43.13M	2025-09
Knight Therapeutics	CAD 3.2M	1.29M	2024-09
Laboratorios Farma	EUR 135.05M	49.84M	2023-12
Malin Corporation	EUR -1.1M	400K	2024-12
Medical Developments International	AUD -480K	662K	2025-06
Moderna	USD -857M	597M	2025-12
Nektar Therapeutics	USD -34.34M	15.43M	2024-09
Neuren Pharmaceuticals	AUD 5.45M	171.24M	2025-06
Neurocrine Biosciences	USD 227.9M	11.4M	2025-12
Novartis	USD 4.5B	363M	2025-09
Omeros	USD -35.41M	23.75M	2024-09
OPKO Health	USD -53.52M	6.46M	2025-09
Organigram Holdings	CAD -28.05M	7.76M	2025-09
Ovoca Bio	EUR -5.65M	3.45M	2022-06
Pfizer	USD 4.65B	3.99B	2025-12
Pharma Mar	EUR -3.96M	28.06M	2025-09
PTC Therapeutics	USD 3.49M	38.35M	2025-09
Qiagen NV	USD 121.88M	15.41M	2025-12
Regeneron Pharmaceuticals	USD 898.6M	211.3M	2025-12
Roche Holding	CHF 9.56B	3.8B	2025-12
Sarepta Therapeutics	USD -62.88M	178.46M	2025-09
Sartorius	EUR 150.1M	11.7M	2025-09
Sino Biopharmaceutical	CNY 5.18B	3.32B	2025-06
Tilray	USD -20.01M	9.34M	2025-09
Ultragenyx Pharmaceutical	USD -114M	56.89M	2025-12
Vertex Pharmaceuticals	USD 1.26B	24.5M	2025-12
Zz Pientze Pharmaceu	CNY 501.33M	52.54M	2025-09

Ionis Pharmaceuticals Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.